These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

202 related articles for article (PubMed ID: 31132287)

  • 1. Asenapine for the treatment of bipolar disorder.
    Marazziti D; Mucci F; Falaschi V; Dell'Osso L
    Expert Opin Pharmacother; 2019 Aug; 20(11):1321-1330. PubMed ID: 31132287
    [No Abstract]   [Full Text] [Related]  

  • 2. A Review of Asenapine in the Treatment of Bipolar Disorder.
    Vieta E; Montes JM
    Clin Drug Investig; 2018 Feb; 38(2):87-99. PubMed ID: 29067671
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Asenapine review, part II: clinical efficacy, safety and tolerability.
    Citrome L
    Expert Opin Drug Saf; 2014 Jun; 13(6):803-30. PubMed ID: 24793161
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Asenapine for schizophrenia and bipolar disorder: a review of the efficacy and safety profile for this newly approved sublingually absorbed second-generation antipsychotic.
    Citrome L
    Int J Clin Pract; 2009 Dec; 63(12):1762-84. PubMed ID: 19840150
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Use of asenapine as add-on therapy in the treatment of bipolar disorder: a comprehensive review and case series.
    Dell'Osso B; Cremaschi L; Palazzo MC; Spagnolin G; Cattaneo A; Grancini B; Maggi M; Altamura AC
    Expert Opin Drug Saf; 2014 Sep; 13(9):1199-208. PubMed ID: 25084462
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Asenapine: a review of its use in the management of mania in adults with bipolar I disorder.
    Chwieduk CM; Scott LJ
    CNS Drugs; 2011 Mar; 25(3):251-67. PubMed ID: 21323396
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Asenapine: a clinical review of a second-generation antipsychotic.
    Stoner SC; Pace HA
    Clin Ther; 2012 May; 34(5):1023-40. PubMed ID: 22494521
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Efficacy and tolerability of asenapine for acute mania in bipolar I disorder: meta-analyses of randomized-controlled trials.
    Vita A; De Peri L; Siracusano A; Sacchetti E;
    Int Clin Psychopharmacol; 2013 Sep; 28(5):219-27. PubMed ID: 23719049
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Asenapine for the treatment of manic and mixed episodes associated with bipolar I disorder: from clinical research to clinical practice.
    Fagiolini A; Forgione RN; Morana B; Maccari M; Goracci A; Bossini L; Pellegrini F; Cuomo A; Casamassima F
    Expert Opin Pharmacother; 2013 Mar; 14(4):489-504. PubMed ID: 23356509
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Asenapine as adjunctive treatment for acute mania associated with bipolar disorder: results of a 12-week core study and 40-week extension.
    Szegedi A; Calabrese JR; Stet L; Mackle M; Zhao J; Panagides J;
    J Clin Psychopharmacol; 2012 Feb; 32(1):46-55. PubMed ID: 22198448
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Antipsychotics in bipolar disorders].
    Vacheron-Trystram MN; Braitman A; Cheref S; Auffray L
    Encephale; 2004; 30(5):417-24. PubMed ID: 15627046
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Asenapine for long-term treatment of bipolar disorder: a double-blind 40-week extension study.
    McIntyre RS; Cohen M; Zhao J; Alphs L; Macek TA; Panagides J
    J Affect Disord; 2010 Nov; 126(3):358-65. PubMed ID: 20537396
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Asenapine in bipolar disorder: efficacy, safety and place in clinical practice].
    Samalin L; Tixeront C; Llorca PM
    Encephale; 2012 Jun; 38(3):257-65. PubMed ID: 22726414
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Asenapine Treatment in Pediatric Patients with Bipolar I Disorder or Schizophrenia: A Review.
    Stepanova E; Grant B; Findling RL
    Paediatr Drugs; 2018 Apr; 20(2):121-134. PubMed ID: 29170943
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cost-effectiveness of asenapine in the treatment of bipolar I disorder patients with mixed episodes.
    Sawyer L; Azorin JM; Chang S; Rinciog C; Guiraud-Diawara A; Marre C; Hansen K
    J Med Econ; 2014 Jul; 17(7):508-19. PubMed ID: 24720805
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Current Trends on Antipsychotics: Focus on Asenapine.
    Marazziti D; Piccinni A; Baroni S; Mungai F; Presta S; Mucci F; Dell'Osso L
    Curr Med Chem; 2016; 23(21):2204-16. PubMed ID: 27222264
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Use of asenapine in clinical practice for the management of bipolar mania.
    Young AH; Altamura AC; González-Pinto AM; Millet B; Wiedemann K
    J Psychopharmacol; 2013 Apr; 27(4 Suppl):3-13. PubMed ID: 23535350
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The preclinical profile of asenapine: clinical relevance for the treatment of schizophrenia and bipolar mania.
    Tarazi FI; Neill JC
    Expert Opin Drug Discov; 2013 Jan; 8(1):93-103. PubMed ID: 23121334
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Long-term Safety of Asenapine in Pediatric Patients Diagnosed With Bipolar I Disorder: A 50-Week Open-Label, Flexible-Dose Trial.
    Findling RL; Landbloom RL; Mackle M; Wu X; Snow-Adami L; Chang K; Durgam S
    Paediatr Drugs; 2016 Oct; 18(5):367-78. PubMed ID: 27461426
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Asenapine: Pharmacological Aspects and Role in Psychiatric Disorders.
    Reyad AA; Mishriky R
    Psychiatr Danub; 2019 Jun; 31(2):157-161. PubMed ID: 31291219
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.